[HTML][HTML] Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients

BL Pierce, R Ballard-Barbash, L Bernstein… - Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
BL Pierce, R Ballard-Barbash, L Bernstein, RN Baumgartner, ML Neuhouser, MH Wener…
Journal of Clinical Oncology, 2009ncbi.nlm.nih.gov
Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast
Cancer Patients - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC2717751 Other
Formats PDF (128K) Actions Cite Collections Share Permalink Copy RESOURCES Similar
articles Cited by other articles Links to NCBI Databases Journal List J Clin Oncol PMC2717751 …
Abstract
Purpose
Chronic inflammation is believed to contribute to the development and progression of breast cancer. Systemic C-reactive protein (CRP) and serum amyloid A (SAA) are measures of low-grade chronic inflammation and potential predictors of cancer survival.
ncbi.nlm.nih.gov